Michael Gong, M.D., Ph.D.
| Appointed: |
2007 |
| Gender: |
Male |
| Languages: |
English |
Regional Urology
Taussig Cancer Institute
Biographical Sketch
Michael C. Gong, MD, PhD, is a staff physician in the Glickman Urological and Kidney Institute and Director of Urologic Oncology at Hillcrest Hospital. He specializes in cancer of the kidney, prostate, and bladder. He is a board-certified urologist and a highly skilled robotic and laparoscopic surgeon. He is a member of the American Urologic Association and the American Society of Clinical Oncology.
Dr. Gong graduated from Pritzker School of Medicine at the University of Chicago. He completed his residency in urology at Stanford University Medical Center in California and his fellowship training at Memorial Sloan-Kettering Cancer Center in New York. He was appointed to Cleveland Clinic in 2007.
Dr. Gong was recognized as the American Foundation for Urologic Disease Research Scholar and received the Medical Scientist Training Program Scholarship. He also serves as a reviewer for the Journal of Urology.
Dr. Gong conducts research in the detection and treatment of prostate cancer, minimally invasive surgical approaches to bladder cancer, and the surgical management of advanced renal cell carcinoma.
Describing his philosophy about patient care, Dr. Gong says: “A patient is often faced with anxiety and uncertainty of disease management and outcomes. A physician should compassionately guide the patient through treatment decisions and tailor clinical management to individual needs.
"I appreciate the opportunity to participate in clinical care and strive to educate each patient and address their problems and concerns. As important, I also truly enjoy another side of medicine, the ability to establish long-term relationships with patients and their families.”
Education & Fellowships
| Medical School: | University of Chicago Pritzker School of Medicine, Chicago, IL |
|
| Internship: | Stanford University Hospital, General Surgery, Stanford, CA |
| Residency: | Stanford University Hospital, Urology, Stanford, CA |
| Residency: | Stanford University Hospital, General Surgery, Stanford, CA |
| Fellowship: | Memorial Sloan-Kettering Cancer Center, Urologic Oncology, New York, NY |
| Other Education: | (Graduate) University of Chicago Pritzker School of Medicine, Chicago, IL |
| Other Education: | (Undergraduate) University of Chicago, Chicago, IL |
Certifications
Specialty Interests
Robotic and laparoscopic surgery, prostate cancer, kidney cancer, bladder cancer.
Professional Memberships
- American Urological Association
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Gong’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
